SAFC Pharma has commissioned a high-potency API conjugates suite at its St Louis site to support oncology drug development. The suite will accommodate early-stage clinical supplies with the capability to expand production up to commercial-scale.
Pharmaceutical Online
Wednesday 1 October 2008
SAFC commissions HPAPI facility
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment